Evidence map›Paper›PMID 7578521›Full record

ArticleAnnals of hematology1995

Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.

H Schönbohn, M Schuler, K Kolbe, C Peschel, C Huber, W Bemb, W E Aulitzky

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of hematology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The CXCL8-CXCR1/2 pathways in cancer.Cytokine & growth factor reviews · 2016
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

H SchönbohnDepartment of Microbiology, University Hospital Mainz, Germany.
M Schuler
K Kolbe
C Peschel
C Huber
W Bemb
W E Aulitzky
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma levels of IL-1, IL-6, IL-8, IL1-RA, TNF alpha, and G-CSF were prospectively studied during 23 chemotherapy cycles of 20 patients suffering from acute myelogenous leukemia. Increased plasma levels of IL-6, IL-8, and G-CSF were observed in patients with febrile neutropenia and/or major infection. Plasma levels of IL-6, IL-1, TNF alpha and IL-1-RA measured 1 day before and 1 day after the onset of febrile episodes did not accurately predict the development of major infection. In contrast, IL-8 plasma levels were significantly higher in those patients who subsequently developed major infection. The question whether IL-8 plasma levels identify high risk or low risk patients with sufficient specificity and sensitivity has to be answered in large scale clinical trials.

Indexed as

AdolescentAdultAnimalsAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCytarabineCytokinesDacarbazineFemaleFeverGranulocyte Colony-Stimulating FactorHumansInterleukin-1Interleukin 1 Receptor Antagonist ProteinInterleukin-2Interleukin-6Antimetabolites, AntineoplasticCytarabineCytokinesDacarbazineGranulocyte Colony-Stimulating FactorIL1RN protein, humanInterleukin-1Interleukin 1 Receptor Antagonist ProteinInterleukin-2Interleukin-6Interleukin-8MitoxantroneNimustineSialoglycoproteinsTumor Necrosis Factor-alphaVincristine

Identifiers

PMID7578521
OpenAlexW2000054190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.